Cargando…

Empagliflozin reduces markers of acute kidney injury in patients with acute decompensated heart failure

AIMS: In this prospective, placebo‐controlled, double‐blind, exploratory study, we examined early and more delayed effects of empagliflozin treatment on haemodynamic parameters (primary endpoint: cardiac output) and kidney function including parameters of acute kidney injury (AKI) in patients with a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thiele, Kirsten, Rau, Matthias, Hartmann, Niels‐Ulrik Korbinian, Möller, Marcus, Möllmann, Julia, Jankowski, Joachim, Keszei, András P., Böhm, Michael, Floege, Jürgen, Marx, Nikolaus, Lehrke, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288802/ https://www.ncbi.nlm.nih.gov/pubmed/35611683 http://dx.doi.org/10.1002/ehf2.13955

Ejemplares similares

Empagliflozin does not change cardiac index nor systemic vascular resistance but rapidly improves left ventricular filling pressure in patients with type 2 diabetes: a randomized controlled study
por: Rau, Matthias, et al.
Publicado: (2021)

Effects of empagliflozin on markers of calcium and phosphate homeostasis in patients with type 2 diabetes – Data from a randomized, placebo-controlled study
por: Rau, Matthias, et al.
Publicado: (2022)

Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options
por: Jankowski, Joachim, et al.
Publicado: (2021)

Efficacy and Safety of Empagliflozin Continuation in Patients with Type 2 Diabetes Hospitalised for Acute Decompensated Heart Failure
por: Pérez-Belmonte, Luis M., et al.
Publicado: (2021)

Effects of COPD on Left Ventricular and Left Atrial Deformation in Patients with Acute Myocardial Infarction: Strain Analysis Using Speckle-Tracking Echocardiography
por: Grebe, Julian, et al.
Publicado: (2022)

Empagliflozin Increases Cardiac Energy Production in Diabetes: Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors
por: Verma, Subodh, et al.
Publicado: (2018)

Human and mouse non‐targeted metabolomics identify 1,5‐anhydroglucitol as SGLT2‐dependent glycemic marker
por: Kappel, Ben A., et al.
Publicado: (2021)

Reduced post-operative DPP4 activity associated with worse patient outcome after cardiac surgery
por: Noels, Heidi, et al.
Publicado: (2018)

The Cardio-Kidney Patient: Epidemiology, Clinical Characteristics and Therapy
por: Schuett, Katharina, et al.
Publicado: (2023)

The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE(−/−) mice by blocking monocyte/macrophage activation
por: Kahles, Florian, et al.
Publicado: (2018)

Empagliflozin in acute myocardial infarction: the EMMY trial( )
por: von Lewinski, Dirk, et al.
Publicado: (2022)

Peptide YY (PYY) Is Associated with Cardiovascular Risk in Patients with Acute Myocardial Infarction
por: Haj-Yehia, Elias, et al.
Publicado: (2020)

Acute decompensated pulmonary hypertension
por: Savale, Laurent, et al.
Publicado: (2017)

Dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the DAPA-CKD trial
por: Marx, Nikolaus, et al.
Publicado: (2021)

Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism
por: Stöhr, Robert, et al.
Publicado: (2022)

Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial
por: Biegus, Jan, et al.
Publicado: (2022)

Repetitive Acute Hemodynamic Load: Progression From Systolic Decompensation to Cellular/Extracellular Compensation to Diastolic Decompensation
por: Zile, Michael R., et al.
Publicado: (2019)

High-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting Mechanisms
por: Schuett, Katharina Andrea, et al.
Publicado: (2015)

Post-cardiac injury syndrome after transcatheter mitral valve repair using MitraClip system: a case report
por: Alachkar, Mhd Nawar, et al.
Publicado: (2020)

Lack of correlation between different congestion markers in acute decompensated heart failure
por: Haag, Svenja, et al.
Publicado: (2022)

Effects of Transcatheter Mitral Valve Repair Using MitraClip(®) Device on Sleep Disordered Breathing in Patients with Mitral Valve Regurgitation
por: Daher, Ayham, et al.
Publicado: (2021)

Acute Decompensated Heart Failure Update
por: Teerlink, John R, et al.
Publicado: (2015)

Acute Kidney Disease After Acute Decompensated Heart Failure
por: Chen, Jia-Jin, et al.
Publicado: (2022)

Acute Lymphoblastic Leukemia Presenting with Acute Decompensated Cardiac Failure
por: Abdelghani, Mohamed Salah, et al.
Publicado: (2023)

Association of Glucose‐Dependent Insulinotropic Polypeptide Levels With Cardiovascular Mortality in Patients With Acute Myocardial Infarction
por: Kahles, Florian, et al.
Publicado: (2021)

US elections: treating the acute-on-chronic decompensation
por: Tsai, Alexander C, et al.
Publicado: (2020)

Iron Deficiency in Acute Decompensated Heart Failure
por: Beale, Anna, et al.
Publicado: (2019)

Hypoalbuminemia in Patients with Acute Decompensated Heart Failure
por: Imamura, Teruhiko
Publicado: (2019)

The Clinical Challenges of Diagnosing Acutely Decompensating Amyloidosis
por: Bayanzay, Karim, et al.
Publicado: (2020)

Acute Myeloid Leukemia Masquerading as Decompensated Cirrhosis
por: Ahdi, Hardeep S, et al.
Publicado: (2022)

Empagliflozin Reduces Interleukin-6 Levels in Patients with Heart Failure
por: Gotzmann, Michael, et al.
Publicado: (2023)

Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute‐on‐chronic liver failure
por: Balcar, Lorenz, et al.
Publicado: (2021)

Adverse Side Effects: Empagliflozin-Related Acute Pancreatitis Case Report
por: Zeidan, Bassem S, et al.
Publicado: (2020)

Comparison of Canagliflozin, Dapagliflozin and Empagliflozin Added to Heart Failure Treatment in Decompensated Heart Failure Patients With Type 2 Diabetes Mellitus
por: Nakagaito, Masaki, et al.
Publicado: (2019)

Management of acutely decompensated chronic thromboembolic pulmonary hypertension in late pregnancy: a case report
por: Valko, Luca, et al.
Publicado: (2019)

Acute decompensation boosts hepatic collagen type III deposition and deteriorates experimental and human cirrhosis
por: Praktiknjo, Michael, et al.
Publicado: (2018)

Percutaneous Ventricular Assist Devices and ECMO in the Management of Acute Decompensated Heart Failure
por: Lawson, William E, et al.
Publicado: (2015)

The Role of Vitamin D(3) as an Independent Predicting Marker for One-Year Mortality in Patients with Acute Heart Failure
por: Thiele, Kirsten, et al.
Publicado: (2022)

Extracorporal hemodialysis with acute or decompensated chronical hepatic failure
por: Hessel, Franz, et al.
Publicado: (2006)

Use of carperitide infusion for acutely decompensated heart failure
por: Morita, Yoshihisa, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8a9ml5ksgj9bvhlpi0u6fku4i6